Cohort study on osteoporosis in China
Multicenter Cohort Study on Osteoporosis in the Middle-aged and Elderly People in Shanghai, China
This study is trying to understand osteoporosis in middle-aged and older people in China by looking at their health habits and history through questionnaires and blood tests.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50000 (estimated) |
| Ages | 45 Years to 79 Years |
| Sex | All |
| Sponsor | Shanghai University of Traditional Chinese Medicine Academic / other |
| Locations | 12 sites (Shenzhen, Guangdong and 11 other locations) |
| Trial ID | NCT02958020 on ClinicalTrials.gov |
What this trial studies
This multicenter cohort study investigates osteoporosis among middle-aged and elderly residents across nine cities in China. It aims to enroll at least 3000 participants, focusing on demographic factors, lifestyle habits, and health history to assess osteoporosis risk. Participants will complete questionnaires and undergo blood tests to evaluate their health status and risk factors related to osteoporosis. The study seeks to gather comprehensive data to better understand osteoporosis in the Chinese population.
Who should consider this trial
Good fit: Ideal candidates for this study are middle-aged and elderly permanent residents of China, specifically women aged 45 to 79 and men aged 50 to 79.
Not a fit: Patients with severe mental or physical diseases, acute infectious diseases, or those who are lactating or pregnant may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into osteoporosis risk factors and improve prevention strategies for patients.
How similar studies have performed: Other studies have shown success in similar cohort approaches to understanding osteoporosis, indicating that this methodology is well-established.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * permanent residents * women aged from 45 to 79, and men aged from 50 to 79 Exclusion Criteria: * severe mental diseases, physical diseases or acute infectious diseases who could not cooperate with the survey. * lactating or pregnant women.
Where this trial is running
Shenzhen, Guangdong and 11 other locations
- Shenzhen Pingle Orthopedic Hospital — Shenzhen, Guangdong, China (Recruiting)
- First People's Hospital of Nankang District, Ganzhou City — Ganzhou, Jiangxi, China (Recruiting)
- Shandong Provincial Hospital of Traditional Chinese Medicine — Jinan, Shandong, China (Recruiting)
- Yunnan Provincial Hospital of Traditional Chinese Medicine — Kunming, Yunnan, China (Not_yet_recruiting)
- Dongzhimen Hospital, Beijing — Beijing, China (Recruiting)
- Wangjing Hospital, China Academy of Chinese Medical Sciences — Beijing, China (Recruiting)
- Affiliated Hospital of Changchun University of Traditional Chinese Medicine — Changchun, China (Recruiting)
- Guangdong Provincial Hospital of Traditional Chinese Medicine — Guangzhou, China (Recruiting)
- Guangzhou Kingmed Diagnostics Co., Ltd. — Guangzhou, China (Recruiting)
- The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine — Guangzhou, China (Recruiting)
- Gansu Provincial Hospital of Traditional Chinese Medicine — Lanzhou, China (Recruiting)
- Longhua Hospital, Shanghai University of TCM — Shanghai, China (Recruiting)
Study contacts
- Principal investigator: Yongjun Wang — Shanhgai University of TCM
- Study coordinator: Yongjun Wang
- Email: yjwang88@hotmail.com
- Phone: 86-21-64385700
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.